Is microsatellite instability a prognostic marker in gastric cancer?: A systematic review with meta-analysis

Journal of Surgical Oncology

Volumn 110, Issue 2, 2014, Pages 129-135

  Choi, Yoon Young ^a   Bae, Jung Min ^b   An, Ji Yeong ^a   Kwon, In Gyu ^a   Cho, In ^a   Shin, Hyun Beak ^a   Eiji, Tanaka ^a,c   Aburahmah, Mohammad ^a,d   Kim, Hyung Il ^a   Cheong, Jae Ho ^a   Hyung, Woo Jin ^a   Noh, Sung Hoon ^a  

^a Yonsei University College of Medicine   (South Korea)

^b The Catholic University of Korea   (South Korea)

^c KYOTO UNIVERSITY   (Japan)

^d KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

Author keywords

gastric cancer; MSI; prognosis

Indexed keywords

CANCER PROGNOSIS; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; DISEASE FREE SURVIVAL; GASTRECTOMY; HUMAN; LYMPH NODE METASTASIS; META ANALYSIS; MICROSATELLITE INSTABILITY; OVERALL SURVIVAL; PRIORITY JOURNAL; REVIEW; STOMACH CANCER; SYSTEMATIC REVIEW;

GASTRIC CANCER; MSI; PROGNOSIS;

ADENOCARCINOMA; GENETIC MARKERS; HUMANS; MICROSATELLITE INSTABILITY; MODELS, STATISTICAL; PROGNOSIS; STOMACH NEOPLASMS; SURVIVAL ANALYSIS;

EID: 84904047894     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.23618     Document Type: Review

References (61)

1. Crew KD, Neugut AI,: Epidemiology of gastric cancer. World J Gastroenterol 2006; 12: 354-362. (Pubitemid 43329250)
2. Yamamoto H, Adachi Y, Taniguchi H, et al.: Interrelationship between microsatellite instability and microRNA in gastrointestinal cancer. World J Gastroenterol 2012; 18: 2745-2755.
3. Lynch HT, Smyrk TC, Watson P, et al.: Genetics, natural history, tumor spectrum, and pathology of hereditary nonpolyposis colorectal cancer: An updated review. Gastroenterology 1993; 104: 1535-1549. (Pubitemid 23235432)
4. Gryfe R, Kim H, Hsieh ET, et al.: Tumor microsatellite instability and clinical outcome in young patients with colorectal cancer. N Engl J Med 2000; 342: 69-77. (Pubitemid 30036597)
5. Popat S, Hubner R, Houlston RS,: Systematic review of microsatellite instability and colorectal cancer prognosis. J Clin Oncol 2005; 23: 609-618. (Pubitemid 46224239)
6. Lee HS, Choi SI, Lee HK, et al.: Distinct clinical features and outcomes of gastric cancers with microsatellite instability. Mod Pathol 2002; 15: 632-640. (Pubitemid 34666467)
7. Falchetti M, Saieva C, Lupi R, et al.: Gastric cancer with high-level microsatellite instability: Target gene mutations, clinicopathologic features, and long-term survival. Hum Pathol 2008; 39: 925-932.
8. Moher D, Liberati A, Tetzlaff J, et al.: Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. Br Med J 2009; 339: b2535.
9. Parmar MK, Torri V, Stewart L,: Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat Med 1998; 17: 2815-2834. (Pubitemid 28562978)
10. Tierney JF, Stewart LA, Ghersi D, et al.: Practical methods for incorporating summary time-to-event data into meta-analysis. Trials 2007; 8: 16.
11. Cho HJ, Kim J, Im S, et al.: Clinicopathologic characteristics of microsatellite instability (MSI) tumors in resected gastric cancer patients. J Clin Oncol 2010; 28: 15 SUPPL. 1.
12. Seruca R, Santos NR, David L, et al.: Sporadic gastric carcinomas with microsatellite instability display a particular clinicopathologic profile. Int J Cancer 1995; 64: 32-36.
13. Dos Santos NR, Seruca R, Constancia M, et al.: Microsatellite instability at multiple loci in gastric carcinoma: Clinicopathologic implications and prognosis. Gastroenterology 1996; 110: 38-44. (Pubitemid 26021602)
14. Kim H, An JY, Noh SH, et al.: High microsatellite instability predicts good prognosis in intestinal-type gastric cancers. J Gastroenterol Hepatol 2011; 26: 585-592.
15. Chiaravalli AM, Feltri M, Bertolini V, et al.: Intratumour T cells, their activation status and survival in gastric carcinomas characterised for microsatellite instability and Epstein-Barr virus infection. Virchows Arch 2006; 448: 344-353. (Pubitemid 43357652)
16. Ottini L, Palli D, Falchetti M, et al.: Microsatellite instability in gastric cancer is associated with tumor location and family history in a high-risk population from Tuscany. Cancer Res 1997; 57: 4523-4529. (Pubitemid 27441056)
17. Roviello F, Corso G, Caruso S, et al.: Correlation of microsatellite instability at multiple loci with long-term survival in advanced gastric carcinoma. Eur J Surg Oncol 2010; 36: 1019.
18. de Manzoni G, di Leo A, Castelli A, et al.: Advanced gastric adenocarcinoma with RER+ phenotype presents a good prognosis after 5 years of curative resection. G Chir 2001; 22: 9-13.
19. Hayden JD, Martin IG, Cawkwell L, et al.: The role of microsatellite instability in gastric carcinoma. Gut 1998; 42: 300-303. (Pubitemid 28212189)
20. Zenilman ME,: Correlation of microsatellite instability at multiple loci with long-term survival in advanced gastric carcinoma-Invited critique. Arch Surg 2009; 144: 727.
21. Bataille F, Rummele P, Dietmaier W, et al.: Alterations in p53 predict response to preoperative high dose chemotherapy in patients with gastric cancer. J Clin Pathol Mol Pathol 2003; 56: 286-292. (Pubitemid 37243921)
22. Yashiro M, Inoue T, Nishioka N, et al.: Allelic imbalance at p53 and microsatellite instability are predictive markers for resistance to chemotherapy in gastric carcinoma. Ann Surg Oncol 2009; 16: 2926-2935.
23. Ott K, Vogelsang H, Mueller J, et al.: Chromosomal instability rather than p53 mutation is associated with response to neoadjuvant cisplatin-based chemotherapy in gastric carcinoma. Clin Cancer Res 2003; 9: 2307-2315. (Pubitemid 36687657)
24. Lu BJ, Lai M, Cheng L, et al.: Gastric medullary carcinoma, a distinct entity associated with microsatellite instability-H, prominent intraepithelial lymphocytes and improved prognosis. Histopathology 2004; 45: 485-492. (Pubitemid 39524323)
25. Mori M, Nakashima H, Mimori K, et al.: [Clinical significance of genetic instability in gastrointestinal cancers]. Nihon Rinsho 1996; 54: 1025-1030.
26. Migliavacca M, Ottini L, Bazan V, et al.: TP53 in gastric cancer: Mutations in the L3 loop and LSH motif DNA-binding domains of TP53 predict poor outcome. J Cell Physiol 2004; 200: 476-485. (Pubitemid 39006940)
27. Choi SW, Choi JR, Chung YJ, et al.: Prognostic implications of microsatellite genotypes in gastric carcinoma. Int J Cancer 2000; 89: 378-383.
28. Zhang H, Liang H, Zhan ZL, et al.: Expressions and the clinical significance of MGMT, hMLH1 in human gastric carcinoma. Chin J Cancer Prev Treat 2007; 14: 593-596. (Pubitemid 46864151)
29. Kitajima Y, Miyazaki K, Matsukura S, et al.: Loss of expression of DNA repair enzymes MGMT, hMLH1, and hMSH2 during tumor progression in gastric cancer. Gastric Cancer 2003; 6: 86-95. (Pubitemid 36829962)
30. Baba H, Korenaga D, Kakeji Y, et al.: DNA ploidy and its clinical implications in gastric cancer. Surgery 2002; 131: S63-S70. (Pubitemid 34118618)
31. Ragnarsson G, Eiriksdottir G, Johannsdottir JT, et al.: Loss of heterozygosity at chromosome 1p in different solid human tumours: Association with survival. Br J Cancer 1999; 79: 1468-1474. (Pubitemid 29116806)
32. Oki E, Kakeji Y, Baba H, et al.: Impact of loss of heterozygosity of encoding phosphate and tensin homolog on the prognosis of gastric cancer. J Gastroenterol Hepatol 2006; 21: 814-818. (Pubitemid 43793276)
33. Noguchi T, Muller W, Wirtz HC, et al.: FHIT gene in gastric cancer: Association with tumour progression and prognosis. J Pathol 1999; 188: 378-381. (Pubitemid 29327435)
34. Suzuki S, Egami K, Sasajima K, et al.: Comparative study between DNA copy number aberrations determined by quantitative microsatellite analysis and clinical outcome in patients with stomach cancer. Clin Cancer Res 2004; 10: 3013-3019. (Pubitemid 38619677)
35. Hayden JD, Cawkwell L, Quirke P, et al.: Prognostic significance of microsatellite instability in patients with gastric carcinoma. Eur J Cancer 1997; 33: 2342-2346. (Pubitemid 28129174)
36. Oliveira C, Seruca R, Seixas M, et al.: The clinicopathological features of gastric carcinomas with microsatellite instability may be mediated by mutations of different 'target genes': A study of the TGF(beta) RII, IGFII R, and BAX genes. Am J Pathol 1998; 153: 1211-1219. (Pubitemid 28465844)
37. Wirtz HC, Muller W, Noguchi T, et al.: Prognostic value and clinicopathological profile of microsatellite instability in gastric cancer. Clin Cancer Res 1998; 4: 1749-1754. (Pubitemid 28304738)
38. Iacopetta BJ, Soong R, House AK, et al.: Gastric carcinomas with microsatellite instability: Clinical features and mutations to the TGF-(beta) type II receptor, IGFII receptor, and BAX genes. J Pathol 1999; 187: 428-432. (Pubitemid 29118274)
39. Yamamoto H, Perez-Piteira J, Yoshida T, et al.: Gastric cancers of the microsatellite mutator phenotype display characteristic genetic and clinical features. Gastroenterology 1999; 116: 1348-1357. (Pubitemid 29258883)
40. Schneider BG, Bravo JC, Roa JC, et al.: Microsatellite instability, prognosis and metastasis in gastric cancers from a low-risk population. Int J Cancer 2000; 89: 444-452.
41. Pe PA, Azcoita MM, Alonso A, et al.: Prognostic significancce of high microsatellite instability in a Spanish series of gastric adenocarcinomas. Anticancer Res 2000; 20: 4009-4014. (Pubitemid 32002314)
42. Chiaravalli A, Cornaggia M, Furlan D, et al.: The role of histological investigation in prognostic evaluation of advanced gastric cancer: Analysis of histological structure and molecular changes compared with invasive pattern and stage. Virchows Arch 2001; 439: 158-169. (Pubitemid 32758909)
43. De Manzoni G, Tomezzoli A, Di Leo A, et al.: Clinical significance of mutator phenotype and chromosome 17p and 18q allelic loss in gastric cancer. Br J Surg 2001; 88: 419-425. (Pubitemid 32238707)
44. Czopek J, Bialas M, Rudzki Z, et al.: The relationship between gastric cancer cells circulating in the blood and microsatellite instability positive gastric carcinomas. Aliment Pharmacol Ther Suppl 2002; 16: 128-136. (Pubitemid 41771471)
45. Wu MS, Lee CW, Sheu JC, et al.: Alterations of BAT-26 identify a subset of gastric cancer with distinct clinicopathologic features and better postoperative prognosis. Hepatogastroenterology 2002; 49: 285-289.
46. Grogg KL, Lohse CM, Pankratz VS, et al.: Lymphocyte-rich gastric cancer: Associations with epstein-barr virus, microsatellite instability, histology, and survival. Mod Pathol 2003; 16: 641-651. (Pubitemid 36871496)
47. Suzuki K, Ohnami S, Tanabe C, et al.: The genomic damage estimated by arbitrarily primed PCR DNA fingerprinting is useful for the prognosis of gastric cancer. Gastroenterology 2003; 125: 1330-1340. (Pubitemid 37409753)
48. Perez RO, Jacob CE, D'Ottaviano FL, et al.: Microsatellite instability in solitary and sporadic gastric cancer. Rev Hosp Clín 2004; 59: 279-285.
49. An C, Choi IS, Yao JC, et al.: Prognostic significance of CpG island methylator phenotype and microsatellite instability in gastric carcinoma. Clin Cancer Res 2005; 11: 656-663. (Pubitemid 40116892)
50. Beghelli S, De Manzoni G, Barbi S, et al.: Microsatellite instability in gastric cancer is associated with better prognosis in only stage II cancers. Surgery 2006; 139: 347-356.
51. Gazvoda B, Juvan R, Zupanic-Pajnic I, et al.: Genetic changes in Slovenian patients with gastric adenocarcinoma evaluated in terms of microsatellite DNA. Eur J Gastroenterol Hepatol 2007; 19: 1082-1089. (Pubitemid 350125380)
52. Corso G, Pedrazzani C, Marrelli D, et al.: Correlation of microsatellite instability at multiple loci with long-term survival in advanced gastric carcinoma. Arch Surg 2009; 144: 722-727.
53. Oki E, Kakeji Y, Zhao Y, et al.: Chemosensitivity and survival in gastric cancer patients with microsatellite instability. Ann Surg Oncol 2009; 16: 2510-2515.
54. Seo HM, Chang YS, Joo SH, et al.: Clinicopathologic characteristics and outcomes of gastric cancers with the MSI-H phenotype. J Surg Oncol 2009; 99: 143-147.
55. Chen HY, Zhu BH, Zhang CH, et al.: High CpG island methylator phenotype is associated with lymph node metastasis and prognosis in gastric cancer. Cancer Sci 2012; 103: 73-79.
56. An JY, Kim H, Cheong JH, et al.: Microsatellite instability in sporadic gastric cancer: Its prognostic role and guidance for 5-FU based chemotherapy after R0 resection. Int J Cancer 2012; 131: 505-511.
57. Japanese Gastric Cancer A: Japanese classification of gastric carcinoma-2nd English edition. Gastric Cancer 1998; 1: 10-24.
58. Boland CR, Thibodeau SN, Hamilton SR, et al.: A National Cancer Institute Workshop on microsatellite instability for cancer detection and familial predisposition: Development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 1998; 58: 5248-5257. (Pubitemid 28521189)
59. Park B, Choi KS, Lee YY, et al.: Trends in cancer screening rates among Korean men and women: Results from the Korean National Cancer Screening Survey (KNCSS), 2004-2011. Cancer Res Treat 2012; 44: 113-120.
60. Guastadisegni C, Colafranceschi M, Ottini L, et al.: Microsatellite instability as a marker of prognosis and response to therapy: A meta-analysis of colorectal cancer survival data. Eur J Cancer 2010; 46: 2788-2798.
61. Umar A, Boland CR, Terdiman JP, et al.: Revised Bethesda guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst 2004; 96: 261-268. (Pubitemid 38256271)